A molecular approach to apoptosis in the human heart during brain death

Transplantation

Volumn 86, Issue 7, 2008, Pages 977-982

  López, Silvia Pérez ^a   Moreno, Natalia Vázquez ^a   Augusto, Dolores Escudero ^a   González, Aurora Astudillo ^a   Menéndez, Francisco Álvarez ^a   Goñi, Félix Goyache ^b   Hernández, Jesús Otero ^a  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^b Servicio Regional de Investigación y Desarrollo Agroalimentario de Asturias   (Spain)

Author keywords

Apoptosis genes; Brain death; Heart transplant; Organ donor; RT PCR

Indexed keywords

CASPASE 3; CYTOCHROME C; FAS ANTIGEN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; ISOMERASE; PEPTIDYLPROLYL ISOMERASE A; PROTEIN BAX; PROTEIN BCL 2; UNCLASSIFIED DRUG; HIF1A PROTEIN, HUMAN; PRIMER DNA;

ADULT; AGED; APOPTOSIS; ARTICLE; BRAIN DEATH; CONTROLLED STUDY; DONOR; FEMALE; GENE EXPRESSION; HEART; HEART LEFT VENTRICLE; HUMAN; HUMAN TISSUE; MALE; MITRAL VALVE REPLACEMENT; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; BIOLOGICAL MODEL; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; HEART MUSCLE; HEART VALVE REPLACEMENT; HEART VENTRICLE; MIDDLE AGED; MITRAL VALVE PROLAPSE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD95; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BRAIN DEATH; CASPASE 3; CYTOCHROMES C; DNA PRIMERS; FEMALE; GENE EXPRESSION REGULATION; HEART; HEART VALVE PROSTHESIS IMPLANTATION; HEART VENTRICLES; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; MIDDLE AGED; MITRAL VALVE PROLAPSE; MODELS, BIOLOGICAL; MYOCARDIUM; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 56049124585     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318186d6d6     Document Type: Article

References (43)

1. ChamorroC, Romera MA, Silva JA, et al. Can heart donation exclusion factors be overcome? Rev Esp Cardiol 2006; 59: 232.
2. Gallardo A, Anguita M, Franco M, et al. The echocardiographic findings in patients with brain death, the implications for their selection as heart transplant donors. Rev Esp Cardiol 1994; 47: 604.
3. Owen VJ, Burton PBJ, Michel MC, et al. Myocardial dysfunction in donor hearts. A possible etiology. Circulation 1999; 99: 2565.
4. Cooper DK, Novitzky D, Wicomb WN. The pathophysiological effects of brain death on potential donor organs, with particular reference to the heart. Ann R Coll Surg Engl 1989; 71: 261.
5. Novitzky D, Horak A, Cooper DK, et al. Electrocardiographic and his-topathologic changes developing during experimental brain death in the baboon. Transplant Proc 1989; 21(1 Pt 3): 2567.
6. Van Der Hoeven JA, Moshage H, Schuurs T, et al. Brain death induces apoptosis in donor liver of the rat. Transplantation 2003; 76: 1150.
7. Kusaka M, Fukami N, Sasaki H, et al. IP-10, apoptotic genes, and cal-cineurin subtype messenger RNA kinetics occurring in rat renal isografts from brain-dead donors. Transplant Proc 2005; 37: 361.
8. Kirsch M, Bertrand S, Lecerf L, et al. Brain death-induced myocardial dysfunction: A role for apoptosis? Transplant Proc 1999; 31: 1713.
9. Carstens J, Markussen N, Madsen M. The granule exocytosis and Fas/ FasLigand pathways at the time of transplantation and during borderline and acute rejection of human renal allografts. Transplant Proc 2005; 37: 3294.
10. Hes O, Treska V, Hasman D, et al. Determination of apoptotic cells in kidneys from non-heart-beating donors and heart-beating donors using the TUNEL assay:Alimited immunohistochemical method? Trans plant Proc 2002; 34: 1095.
11. Nijboer WN, Schuurs TA, van der Hoeven JA, et al. Effect of brain death on gene expression and tissue activation in human donor kidneys. Transplantation 2004; 78: 978.
12. Yeh T Jr, Wechsler AS, Graham LJ, et al. Acute brain death alters left ventricular myocardial gene expression. J Thorac Cardiovasc Surg 1999; 117: 365.
13. Khoynezhad A, Jalali Z, Tortolani AJ. A synopsis of research in cardiac apoptosis and its application to congestive heart failure [review]. Tex Heart Inst J 2007; 34: 352.
14. Budihardjo I, Oliver H, Lutter M, et al. Biochemical pathways of caspase activation during apoptosis. Annu Rev Cell Dev Biol 1999; 15: 269.
15. Patel T, Gores GJ, Kaufmann SH. The role of proteases during apopto-sis [review]. FASEB J 1996; 10: 587.
16. SaikumarP, Venkatachalam MA. Role of apoptosisin hypoxicischemic damage in the kidney. Semin Nephrol 2003; 23: 511.
17. Kroemer G, Reed JC. Mitochondrial control of cell death. Nat Med 2000; 6: 513.
18. Kunisada K, Tone E, Negoro S, et al. Bcl-xl reduces doxorubicin-induced myocardial damage but fails to control cardiac gene down-regulation. Cardiovasc Res 2002; 53: 936.
19. Saikumar P, Dong Z, Mikhailov V, et al. Apoptosis: Definition, mechanisms, and relevance to disease. Am J Med 1999; 107: 489.
20. Antonsson B. Bax and other pro-apoptotic Bcl-2 family "killerproteins" and their victim the mitochondrion. Cell Tissue Res 2001; 306: 347.
21. Thornberry NA, Lazebnik Y. Caspases: Enemies within. Science 1998; 281: 1312.
22. Birks EJ, Yacoub MH, Burton PS, et al. Activation of apoptotic and inflammatory pathwaysin dysfunctional donor hearts.Transplantation 2000; 70: 1498.
23. Laguens RP, Meckert PM, Martino JS, et al. Identification of programmed cell death (apoptosis) in situ by means of specific labeling of nuclear DNA fragments in heart biopsy samples during acute rejection episodes. J Heart Lung Transplant 1996; 15: 911.
24. Szabolcs MJ, Ravalli S, Minanov O, et al. Apoptosis and increased expression ofinducible nitric oxide synthasein human allograft rejection. Transplantation 1998; 65: 804.
25. Puig M, Ballester M, Matías-Guiu X, et al. Burden of myocardial damage in cardiac allograft rejection: Scintigraphic evidence of myocardial injury and histologic evidence of myocyte necrosis and apoptosis. J Nucl Cardiol 2000; 7: 132.
26. Reeve JL, Duffy AM, O'Brien T, et al. Don't lose heart-Therapeutic value of apoptosis prevention in the treatment of cardiovascular disease. J Cell Mol Med 2005; 9: 609.
27. Gilbert EM, Krueger SK, Murray JL, et al. Echocardiographic evaluation of potential cardiac transplant donors. J Thorac Cardiovasc Surg 1988; 95: 1003.
28. Cook SA, Poole-Wilson PA. Cardiac myocyte apoptosis [review]. Eur Heart J 1999; 20: 1619.
29. Olivetti G, Abbi R,Quaini F,et al. Apoptosis inthe failing human heart. N Engl J Med 1997; 336: 1131.
30. Narula J, Haider N, Virmani R, et al. Apoptosis in myocytes in endstage heart failure. N Engl J Med 1996; 335: 1182.
31. Mallat Z, Tedgui A, Fontaliran F, et al. Evidence of apoptosis in arrhythmogenic right ventricular dysplasia. N Engl J Med 1996; 335: 1190.
32. Toyozaki T, Hiroe M, Tanaka M, et al. Levels of soluble Fas ligand in myocarditis. Am J Cardiol 1998; 82: 246.
33. Pérez S, Royo LJ, Astudillo A, et al. Identifying the most suitable endogenous control for determining gene expression in hearts from organ donors. BMC Mol Biol 2007; 8: 114.
34. Earnshaw WC, Martins LM, Kaufmann SH. Mammalian caspases: Structure, activation, substrates, and functions during apoptosis [review]. Annu Rev Biochem 1999; 68: 383.
35. Yue TL, WangC, Romanic AM, et al. Staurosporine-induced apoptosis in cardiomyocytes: A potential role of caspase-3. J Mol Cell Cardiol 1998; 30: 495.
36. Black SC, Huang JQ, Rezaiefar P, et al. Co-localization of the cysteine protease caspase-3 with apoptotic myocytes after in vivo myocardial ischemia and reperfusion in the rat. J Mol Cell Cardiol 1998; 30: 733.
37. Ashkenazi A. Targeting death and decoy receptors of the tumour-necrosis factor superfamily [review]. Nat Rev Cancer 2002; 2: 420.
38. Adams JM, Cory S. The Bcl-2 protein family: Arbiters of cell survival [review]. Science 1998; 281: 1322.
39. Luo X, Budihardjo I, Zou H, et al. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 1998; 94: 481.
40. Reeve JL, Szegezdi E, Logue SE, et al. Distinct mechanisms of cardio-myocyte apoptosis induced by doxorubicin and hypoxia converge on mitochondria and are inhibitedbyBcl-xL. J Cell Mol Med 2007; 11: 509.
41. Tanaka M, Ito H, Adachi S, et al. Hypoxia induces apoptosis with enhanced expression of Fas antigen messenger RNA in cultured neonatal rat cardiomyocytes. Circ Res 1994; 75: 426.
42. Stroka DM, Burkhardt T, Desbaillets I, et al. HIF-1 is expressed in normoxic tissue and displays an organ-specific regulation under systemic hypoxia. FASEB J 2001; 15: 2445.
43. Schuurs TA, Morariu AM, Ottens PJ, et al. Time-dependent changes in donor brain death related processes. Am J Transplant 2006; 6: 2903.